These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 4975540)
1. [New possibilities of prognosis, therapy and prophylaxis of hemolytic disease of the newborn]. Schreiner EW; Maroni E Praxis; 1968 Mar; 57(9):283-93. PubMed ID: 4975540 [No Abstract] [Full Text] [Related]
6. Management of the Rh-negative gravida. Charles AG; Alpern WM Am Fam Physician; 1971 Mar; 3(3):104-19. PubMed ID: 4101204 [No Abstract] [Full Text] [Related]
7. [Hemolytic disease of the newborn. Prenatal diagnosis, prognosis and intrauterine transfusion in the severely diseased fetus]. Maroni E; Schreiner WE Med Klin; 1969 Mar; 64(13):569-78. PubMed ID: 4891636 [No Abstract] [Full Text] [Related]
8. Diagnosis and treatment of erythroblastosis in the fetus. Liley AW Adv Pediatr; 1968; 15():29-63. PubMed ID: 4966222 [No Abstract] [Full Text] [Related]
9. [Indication and technic of therapy in severe fetal hemolytic disease]. Hofmann D; Mast H Z Geburtshilfe Gynakol; 1967 Oct; 167(3):285-97. PubMed ID: 5597692 [No Abstract] [Full Text] [Related]
10. [The diagnosis and antenatal prevention of hemolytic disease of the newborn in Rh sensitized women]. Persianinov LS; Sidel'nikova VM Akush Ginekol (Mosk); 1971 Aug; 47(8):3-8. PubMed ID: 4342988 [No Abstract] [Full Text] [Related]
11. [Rh isoimmunization: experience with and critical analysis of recent diagnostic and therapeutic criteria]. Bellati U; Noia G; Garzetti GG; Serri FG; Riccardi P; Stabile A Ann Ostet Ginecol Med Perinat; 1981; 102(2):84-94. PubMed ID: 6167190 [No Abstract] [Full Text] [Related]
12. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17. Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861 [TBL] [Abstract][Full Text] [Related]
13. [Experiences with the intraperitoneal fetal transfusion in severe hemolytic disease of the newborn]. Maroni E; Schreiner WE Geburtshilfe Frauenheilkd; 1968 Jan; 28(1):26-41. PubMed ID: 4970142 [No Abstract] [Full Text] [Related]
14. Use of maternal blood for intrauterine transfusions. Eyster ME; Queenan JT; Haber JM Obstet Gynecol; 1969 Nov; 34(5):636-40. PubMed ID: 4981597 [No Abstract] [Full Text] [Related]
15. INTRAUTERINE BLOOD TRANSFUSION OF THE FETUS. CORSTON JM; MORTON BS; ROBINSON SC Can Med Assoc J; 1964 Oct; 91(15):815-7. PubMed ID: 14199111 [No Abstract] [Full Text] [Related]
16. [Prenatal determination of the fetal blood group]. Meroni P; Della Torre L Ann Ostet Ginecol Med Perinat; 1969 Jul; 91(7):497-507. PubMed ID: 4997558 [No Abstract] [Full Text] [Related]
17. The current role of intrauterine fetal transfusion in the management of erythroblastosis fetalis: a review of indications and methods. Halitsky V; Krumholz BA; Schwalb E; Gromisch DS Obstet Gynecol Surv; 1968 Apr; 23(4):301-30. PubMed ID: 4968600 [No Abstract] [Full Text] [Related]
18. [On the problem of intrauterine transfusion in severe hemolytic disease of the newborn]. Kubli F; Schieferstein W Z Geburtshilfe Gynakol; 1966 Oct; 166(1):59-71. PubMed ID: 4961696 [No Abstract] [Full Text] [Related]
20. [Supervision of pregnant women isoimmunized with the rhesus factor. Significance and interpretation of the position of optic indices on the Liley diagram (425 cases)]. Blanchard A; Merger R J Gynecol Obstet Biol Reprod (Paris); 1972 Mar; 1(2):107-31. PubMed ID: 4626034 [No Abstract] [Full Text] [Related] [Next] [New Search]